← Evidence map

ArticleThe New England journal of medicine2018

Durvalumab in Stage III Non-Small-Cell Lung Cancer.

Matteo Santoni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29504721